Cyclacel Pharmaceuticals Inc. (CYCC) Financial Statements (2024 and earlier)

Company Profile

Business Address 200 CONNELL DRIVE
BERKELEY HEIGHTS, NJ 07922
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3,37818,34536,55933,40611,88517,504
Cash and cash equivalents3,37818,34536,55933,40611,88517,504
Receivables      356
Prepaid expense     703543
Deposits current assets      66
Other current assets3414267966103170
Other undisclosed current assets3,7255,6404,3041,9971,3261,148
Total current assets:7,44424,41140,94235,46914,01719,787
Noncurrent Assets
Operating lease, right-of-use asset93142301,2271,264
Property, plant and equipment932641062736
Deposits noncurrent assets1,2592,9161,551   
Total noncurrent assets:1,3613,0901,6451,3331,29136
TOTAL ASSETS:8,80527,50142,58736,80215,30819,823
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities8,1617,3925,2942,4862,4204,451
Accounts payable3,5432,5612,1175148902,719
Accrued liabilities4,6184,8313,1771,9721,5301,732
Total current liabilities:8,1617,3925,2942,4862,4204,451
Noncurrent Liabilities
Long-term debt and lease obligation:   301,0571,191 
Liabilities, other than long-term debt37106    
Operating lease, liability37106301,0571,191
Other undisclosed noncurrent liabilities   (30)  100
Total noncurrent liabilities:37106301,0571,191100
Total liabilities:8,1987,4985,3243,5433,6114,551
Temporary equity, carrying amount  4,494    
Equity
Equity, attributable to parent60715,50937,26333,25911,69715,272
Common stock191061712
Additional paid in capital429,796422,973422,960400,071370,126365,817
Accumulated other comprehensive loss(908)(1,316)(748)(746)(819)(760)
Accumulated deficit(428,282)(406,157)(384,959)(366,072)(357,627)(349,797)
Total equity:60715,50937,26333,25911,69715,272
TOTAL LIABILITIES AND EQUITY:8,80527,50142,58736,80215,30819,823

Income Statement (P&L) ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues420    150
Cost of revenue     (38) 
Gross profit:420   (38)150
Operating expenses(25,873)(27,656)(22,938)(10,636)(9,644)(9,698)
Operating loss:(25,453)(27,656)(22,938)(10,636)(9,682)(9,548)
Nonoperating income (expense)(98)1,741204955556923
Investment income, nonoperating2662101642224331
Gain (loss), foreign currency transaction, before tax(414)2334422101(90)
Other nonoperating income (expense)501,298144891231682
Loss from continuing operations before income taxes:(25,551)(25,915)(22,734)(9,681)(9,126)(8,625)
Income tax benefit2,9964,7173,8471,2361,2961,337
Loss from continuing operations:(22,555)(21,198)(18,887)(8,445)(7,830)(7,288)
Loss before gain (loss) on sale of properties:(18,887)(8,445)(7,830)(7,288)
Net loss attributable to parent:(22,555)(21,198)(18,887)(8,445)(7,830)(7,288)
Preferred stock dividends and other adjustments(201)(201)(201)(3,976)(201)(201)
Net loss available to common stockholders, diluted:(22,756)(21,399)(19,088)(12,421)(8,031)(7,489)

Comprehensive Income ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(22,555)(21,198)(18,887)(8,445)(7,830)(7,288)
Comprehensive loss:(22,555)(21,198)(18,887)(8,445)(7,830)(7,288)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent408(568)(2)73(59)34
Comprehensive loss, net of tax, attributable to parent:(22,147)(21,766)(18,889)(8,372)(7,889)(7,254)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: